Confirmation of these findings was performed by immunostaining of tumor sections with an antibody against CD34, an endothelial cell marker (Fig 4B), followed by quantification of the CD34-positive area or CD34-positive number (Fig 4C). Here, CD34 is linked to neoplasm.